Clinical Trial Update: REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE [Phase 4]

View source ↗

Summary

A Phase 4 trial update announcing initiation of antiretroviral therapy using the bictegravir/emtricitabine/tenofovir alafenamide combination; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)
• Bictegravir (bictegravir)
• Emtricitabine (Emtricitabine)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: CAN Community Health | Conditions: HIV -1 Infection, HIV (Human Immunodeficiency Virus) | Phase 4 | Status: NOT_YET_RECRUITING